New dialysis method aims to cut recovery time for kidney patients
NCT ID NCT05689801
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times
Summary
This pilot study tested an optimized dialysis technique using a special membrane and biofeedback software to see if it helps kidney failure patients recover faster after treatment. 18 patients on standard dialysis who took at least 4 hours to recover were observed. The study measured recovery time and quality of life using simple questionnaires.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Medium Cut-Off membrane (Theranova®) and biofeedback software (HemoControl™)
- What this could lead to
- If successful, this approach could shorten recovery time after dialysis and improve daily quality of life for kidney failure patients.
- What could go wrong
- This is a very small pilot study with only 18 participants, so results may not apply to everyone. The intervention is a technique change, not a new drug, so benefits may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
18 people
The number who actually took part.
- Started
-
Dec 2022
- Finished
-
Oct 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient, male or female (using contraceptives, if of childbearing age), over 18 years of age * Patient on conventional hemodialysis with synthetic membrane for at least 3 months * Patient with a recovery time after the dialysis session ≥ 4 hours * Informed patient who has signed a written consent to participate in the study * Affiliated patient or beneficiary of a social security scheme Exclusion Criteria: * Patient whose seniority of dialysis is less than 3 months * Pregnant woman * Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision * Patient with severe cognitive impairment * Medically unstable or frail patient * Patient who did not sign an informed consent form accepting this research (refusal of consent or absence of signature).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for End-stage renal disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Privé Claude Galien
Quincy-sous-Sénart, 91480, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a deep breath and a hint of lemongrass take the sting out of dialysis needles?
- Can better training get doctors to talk about what matters most to dying veterans?
- Can pedaling during dialysis make red blood cells more flexible?
- 30,000 dialysis patients tracked to map what works
- Donated artery grafts tested as lifeline for dialysis patients
- Does better dialysis keep parathyroid hormone in check?